instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'NIVOLUMAB'? | Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.
Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival <10% and no standard therapy. We report the first case to our knowledge of metastatic EMPD with tre... | 3 MILLIGRAM/KILOGRAM, Q3WK | DrugDosageText | CC BY-NC | 33790764 | 19,101,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | A Diagnostic Dilemma of Antiglutamic Acid Decarboxylase 65 (Anti-GAD 65) and Mycoplasma Pneumoniae Antibodies in a Girl Presenting with Acute-Onset Obsessive-Compulsive Disorder.
Acute-onset obsessive-compulsive disorder can be challenging, especially when triggered by an underlying disease process. Clinicians often tu... | AMOXICILLIN, AZITHROMYCIN ANHYDROUS, FLUOXETINE HYDROCHLORIDE, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33791138 | 19,262,194 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A Diagnostic Dilemma of Antiglutamic Acid Decarboxylase 65 (Anti-GAD 65) and Mycoplasma Pneumoniae Antibodies in a Girl Presenting with Acute-Onset Obsessive-Compulsive Disorder.
Acute-onset obsessive-compulsive disorder can be challenging, especially when triggered by an underlying disease process. Clinicians often tu... | AMOXICILLIN, AZITHROMYCIN ANHYDROUS, FLUOXETINE HYDROCHLORIDE, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33791138 | 19,262,194 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | A Diagnostic Dilemma of Antiglutamic Acid Decarboxylase 65 (Anti-GAD 65) and Mycoplasma Pneumoniae Antibodies in a Girl Presenting with Acute-Onset Obsessive-Compulsive Disorder.
Acute-onset obsessive-compulsive disorder can be challenging, especially when triggered by an underlying disease process. Clinicians often tu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33791138 | 19,262,194 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothyroidism'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin disorder'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stomatitis'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyroid disorder'. | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | ATEZOLIZUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33791204 | 19,152,959 | 2021 |
What was the administration route of drug 'ATEZOLIZUMAB'? | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33791204 | 19,152,959 | 2021 |
What was the administration route of drug 'NIVOLUMAB'? | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33791204 | 19,152,959 | 2021 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33791204 | 19,152,959 | 2021 |
What was the dosage of drug 'ATEZOLIZUMAB'? | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | 1,200 MG/DAY EVERY 3 WEEKS | DrugDosageText | CC BY | 33791204 | 19,152,959 | 2021 |
What was the dosage of drug 'NIVOLUMAB'? | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | INTRAVENOUSLY AT 3 MG/KG OR 240 MG/DAY | DrugDosageText | CC BY | 33791204 | 19,152,959 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Immune checkpoint inhibitor (ICI) therapy has been described to markedly improve patient survival. However, reports describing the antitumor therapeutic... | 200 MG/DAY EVERY 3 WEEKS | DrugDosageText | CC BY | 33791204 | 19,152,959 | 2021 |
What is the weight of the patient? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | 90.7 kg. | Weight | CC BY | 33791318 | 19,137,794 | 2021 |
What was the administration route of drug 'LIDOCAINE'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33791318 | 19,229,124 | 2021 |
What was the administration route of drug 'LISINOPRIL'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | Oral | DrugAdministrationRoute | CC BY | 33791318 | 19,137,794 | 2021 |
What was the administration route of drug 'OXYGEN'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 33791318 | 19,139,134 | 2021 |
What was the administration route of drug 'PROPOFOL'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33791318 | 19,137,794 | 2021 |
What was the dosage of drug 'ACETAMINOPHEN'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'AMLODIPINE BESYLATE'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'APIXABAN'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'ATORVASTATIN'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'LISINOPRIL'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'MAGNESIUM SULFATE'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'METOPROLOL'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'SPIRONOLACTONE'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the dosage of drug 'TAMSULOSIN'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | UNKNOWN | DrugDosageText | CC BY | 33791318 | 19,182,553 | 2021 |
What was the outcome of reaction 'Angioedema'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | Recovered | ReactionOutcome | CC BY | 33791318 | 19,137,794 | 2021 |
What was the outcome of reaction 'Macroglossia'? | Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.
Angioedema with macroglossia is a rare complication of anesthesia. We present a clinical case of post-operative development of angioedema presenting as macroglossia in a patient receiving chronic therapy with lisinopril, who developed sym... | Recovered | ReactionOutcome | CC BY | 33791318 | 19,229,124 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothermia'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoventilation'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,617,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Irregular breathing'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Loss of consciousness'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oxygen saturation decreased'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Poisoning'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,617,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suicide attempt'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | DIAZEPAM | DrugsGivenReaction | CC BY | 33791324 | 19,193,974 | 2021 |
What is the weight of the patient? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | 80 kg. | Weight | CC BY | 33791324 | 19,193,974 | 2021 |
What was the administration route of drug 'DIAZEPAM'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Oral | DrugAdministrationRoute | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Hypothermia'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Hypoventilation'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Irregular breathing'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Loss of consciousness'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Overdose'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Oxygen saturation decreased'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Poisoning'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,617,777 | 2021 |
What was the outcome of reaction 'Suicide attempt'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Case Report: Enhanced Diazepam Elimination With the Molecular Adsorbents Recirculating System (MARS) in Severe Autointoxication: A Survival Case Report.
Objective: Due to the extensive use of diazepam worldwide, self-induced intoxication is very common, yet rarely fatal. Nevertheless, the management of intoxication cau... | Recovered | ReactionOutcome | CC BY | 33791324 | 19,193,974 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amaurosis fugax'. | Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated opht... | LIDOCAINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33791385 | 19,204,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amaurosis'. | Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated opht... | TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33791385 | 19,533,714 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated opht... | LIDOCAINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33791385 | 19,204,479 | 2021 |
What was the administration route of drug 'TRIAMCINOLONE ACETONIDE'? | Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated opht... | Intraocular | DrugAdministrationRoute | CC BY | 33791385 | 19,533,714 | 2021 |
What was the dosage of drug 'LIDOCAINE'? | Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated opht... | 0.2 MILLILITER | DrugDosageText | CC BY | 33791385 | 19,204,479 | 2021 |
What was the outcome of reaction 'Amaurosis fugax'? | Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated opht... | Recovered | ReactionOutcome | CC BY | 33791385 | 19,204,479 | 2021 |
What was the outcome of reaction 'Amaurosis'? | Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated opht... | Recovering | ReactionOutcome | CC BY | 33791385 | 19,533,714 | 2021 |
What was the dosage of drug 'BISOPROLOL'? | Cardiac rehabilitation with intermittent myocardial ischaemia as a new therapeutic option in refractory angina?
A 72-year-old man daily suffered from a refractory angina consecutive to a diffuse coronary artery disease despite optimal medical management. Revascularization could not be performed because of a severe thro... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33792203 | 20,066,322 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary toxicity'. | Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East.
BACKGROUND
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon variant of Hodgkin lymphoma. There is limite... | BLEOMYCIN SULFATE, DACARBAZINE, DOXORUBICIN HYDROCHLORIDE, RITUXIMAB, VINBLASTINE | DrugsGivenReaction | CC BY | 33794818 | 19,626,817 | 2021-04-01 |
What was the outcome of reaction 'Pulmonary toxicity'? | Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East.
BACKGROUND
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon variant of Hodgkin lymphoma. There is limite... | Fatal | ReactionOutcome | CC BY | 33794818 | 19,626,817 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone giant cell tumour'. | Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab.
BACKGROUND
Giant cell tumor of bone is a benign, locally aggressive neoplasm. Surgical resection is the preferred treatment method.... | ADALIMUMAB, METHOTREXATE | DrugsGivenReaction | CC BY | 33794838 | 19,604,501 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab.
BACKGROUND
Giant cell tumor of bone is a benign, locally aggressive neoplasm. Surgical resection is the preferred treatment method.... | ADALIMUMAB, METHOTREXATE | DrugsGivenReaction | CC BY | 33794838 | 19,604,501 | 2021-04-01 |
What was the administration route of drug 'ADALIMUMAB'? | Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab.
BACKGROUND
Giant cell tumor of bone is a benign, locally aggressive neoplasm. Surgical resection is the preferred treatment method.... | Subcutaneous | DrugAdministrationRoute | CC BY | 33794838 | 19,604,501 | 2021-04-01 |
What was the administration route of drug 'METHOTREXATE'? | Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab.
BACKGROUND
Giant cell tumor of bone is a benign, locally aggressive neoplasm. Surgical resection is the preferred treatment method.... | Oral | DrugAdministrationRoute | CC BY | 33794838 | 19,604,501 | 2021-04-01 |
What was the dosage of drug 'ADALIMUMAB'? | Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab.
BACKGROUND
Giant cell tumor of bone is a benign, locally aggressive neoplasm. Surgical resection is the preferred treatment method.... | 20 mg (milligrams). | DrugDosage | CC BY | 33794838 | 19,604,501 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal lymphadenopathy'. | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | CALCITONIN, HYDROXYCHLOROQUINE, IPILIMUMAB, NIVOLUMAB, SODIUM CHLORIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33794867 | 19,228,071 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | CALCITONIN, HYDROXYCHLOROQUINE, IPILIMUMAB, NIVOLUMAB, SODIUM CHLORIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33794867 | 19,228,071 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | CALCITONIN, HYDROXYCHLOROQUINE, IPILIMUMAB, NIVOLUMAB, SODIUM CHLORIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33794867 | 19,228,071 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hilar lymphadenopathy'. | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | CALCITONIN, HYDROXYCHLOROQUINE, IPILIMUMAB, NIVOLUMAB, SODIUM CHLORIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33794867 | 19,228,071 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphadenopathy mediastinal'. | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | CALCITONIN, HYDROXYCHLOROQUINE, IPILIMUMAB, NIVOLUMAB, SODIUM CHLORIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33794867 | 19,228,071 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psoriatic arthropathy'. | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33794867 | 19,166,572 | 2021-04-01 |
What was the administration route of drug 'NIVOLUMAB'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | Other | DrugAdministrationRoute | CC BY | 33794867 | 19,228,071 | 2021-04-01 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33794867 | 19,228,071 | 2021-04-01 |
What was the dosage of drug 'IPILIMUMAB'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | 1 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 33794867 | 19,166,572 | 2021-04-01 |
What was the dosage of drug 'NIVOLUMAB'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | 3 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 33794867 | 19,166,572 | 2021-04-01 |
What was the outcome of reaction 'Hypercalcaemia'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | Recovered | ReactionOutcome | CC BY | 33794867 | 19,230,548 | 2021-04-01 |
What was the outcome of reaction 'Immune-mediated hypothyroidism'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | Recovered | ReactionOutcome | CC BY | 33794867 | 19,166,572 | 2021-04-01 |
What was the outcome of reaction 'Psoriatic arthropathy'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | Recovered | ReactionOutcome | CC BY | 33794867 | 19,166,572 | 2021-04-01 |
What was the outcome of reaction 'Rash'? | Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
BACKGROUND
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia i... | Recovered | ReactionOutcome | CC BY | 33794867 | 19,166,572 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Society for Cardiovascular Magnetic Resonance 2019 Case of the Week series.
The Society for Cardiovascular Magnetic Resonance (SCMR) is an international society focused on the research, education, and clinical application of cardiovascular magnetic resonance (CMR). The SCMR web site ( https://www.scmr.org ) hosts a cas... | ATORVASTATIN, CARBOPLATIN, CARVEDILOL, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33794918 | 19,230,568 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ejection fraction decreased'. | Society for Cardiovascular Magnetic Resonance 2019 Case of the Week series.
The Society for Cardiovascular Magnetic Resonance (SCMR) is an international society focused on the research, education, and clinical application of cardiovascular magnetic resonance (CMR). The SCMR web site ( https://www.scmr.org ) hosts a cas... | ATORVASTATIN, CARBOPLATIN, CARVEDILOL, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33794918 | 19,230,568 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular dysfunction'. | Society for Cardiovascular Magnetic Resonance 2019 Case of the Week series.
The Society for Cardiovascular Magnetic Resonance (SCMR) is an international society focused on the research, education, and clinical application of cardiovascular magnetic resonance (CMR). The SCMR web site ( https://www.scmr.org ) hosts a cas... | ATORVASTATIN, CARBOPLATIN, CARVEDILOL, GEMCITABINE HYDROCHLORIDE, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33794918 | 19,241,395 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Society for Cardiovascular Magnetic Resonance 2019 Case of the Week series.
The Society for Cardiovascular Magnetic Resonance (SCMR) is an international society focused on the research, education, and clinical application of cardiovascular magnetic resonance (CMR). The SCMR web site ( https://www.scmr.org ) hosts a cas... | ATORVASTATIN, CARBOPLATIN, CARVEDILOL, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33794918 | 19,230,568 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aphasia'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,901 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | CYCLOSPORINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33794964 | 19,153,415 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphagia'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,900 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epilepsy'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,901 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Graft versus host disease'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | CYCLOSPORINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33794964 | 19,153,415 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,900 | 2021-04-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.